- 基本信息
|
导师姓名：
|
蔡伟
|
学科代码：
|
100210
|
|
|
性别：
|
男
|
学科名称：
|
外科学
|
|
培养单位：
|
附属瑞金医院
|
三级学科
|
普外
|
|
导师类型：
|
博士生导师
|
专业领域名称：
|
外科学 专业学位
|
|
联系方式：
|
|
专业领域代码：
|
105111
|
|
邮编：
|
|
邮箱地址：
|
caiwei@shsmu.edu.cn
|
- 研究方向 (点击浏览详细信息)
- 社会任职
| |
|
中国抗癌协会肿瘤营养专业委员会外科营养学组副组长
|
|
上海医学会普外科专科分会甲状腺学组组长
|
|
上海医学会普外科专科分会委员
|
|
上海市抗癌协会肿瘤营养与支持治疗专委会副主委
|
|
上海中西医结合学会健康管理学会青年主任委员
|
|
上海中西医结合学会普外科专委会青年副主委
|
|
上海市医院协会院办专委会主任委员
|
- 科研项目
| 82273214 | DENR协作 m6Am RNA修饰调控结直肠癌中巨噬细胞功能的机制研究 | 国家自然科学基金(面上) |
2023-01~2026-12
|
51万元
| 课题负责人 |
| 22-163-13-ZT-002-XXX-XX | XXX（涉密课题） | 中央军委科技委 |
2022-01~2023-12
|
200万元
| 课题负责人 |
| YG2019ZDA15 | 精准控温、加湿及药液雾化CO2气腹装置设计研究 | 交大医工交叉研究基金（重点A类） |
2020-01~2022-12
|
100万元
| 课题负责人 |
| 19441905400 | 可控温、加湿CO2气腹机辅助装置开发 | 市科委（生物医药领域支撑项目） |
2019-04~2022-03
|
25万元
| 课题负责人 |
| YG2015MS62 | 胃癌无创性尿液早期诊断试剂盒与试纸条的研发 | 交大医工交叉基金（面上） |
2016-01~2018-12
|
21万元
| 课题负责人 |
| 14ZR1426100 | CDH-12促进EMT活化Rho信号通路调控大肠癌转移的机制研究 | 市科委（自然基金） |
2014-07~2017-06
|
10万元
| 课题负责人 |
| 114119a4900 | 符合腹腔生理的加热加湿CO2气腹在腹腔镜手术中应用的研究 | 市科委（医学引导） |
2011-01~2013-06
|
10万元
| 课题负责人 |
| 2008Y074 | 虫草多糖抗结直肠癌侵袭转移及调控VEGF表达的临床和基础研究 | 卫生局（青年） |
2009-01~2010-12
|
2万元
| 课题负责人 |
- 学术论文
|
Yang Zheyu, Heng Yu, Zhao Qiwu, Hao Ding, Tao Lei, Deng Xiaxing,, Qiu Weihua
|
The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study
|
Cancer medicine
|
2023
|
12(12), 13270–13278
|
|
Yang Zheyu, Yao Siqiong, Heng Yu, Shen Pengcheng, Lv Tian, Feng Siqi, Tao Lei, Zhang Weituo, Qiu Weihua, Lu Hui,
|
Automated diagnosis and management of follicular thyroid nodules based on the devised small-dataset interpretable foreground optimization network deep learning: a multicenter diagnostic study
|
International journal of surgery
|
2023
|
109(9), 2732–2741
|
|
Yu Heng, Zheyu Yang, Juiming Lin, Qingmei Liu,, Lei Tao
|
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis
|
Oral oncology
|
2022
|
134:106185
|
|
Ruijun Pan, Dingye Yu, Jiajia Hu, Xiao Yang, Chenxing Wang, Luyang Zhang, Pei Xue, Jing Sun, Xiaoping Zhang,
|
SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A
|
Cell Death and Discovery
|
2022
|
16;8(1):263
|
|
Baiwen Chen, Jiajia Hu, Xianting Hu, Huifang Chen, Rujuan Bao, Yatao Zhou, Youqiong Ye, Meixiao Zhan,, Huabin Li, Hua-Bing Li
|
DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion
|
Nature Communications
|
2022
|
19;13(1):2059
|
|
Dingye Yu, Xiao Yang, Jianwei Lin, Zichao Cao, Chenghao Lu, Zheyu Yang, Minhua Zheng, Ruijun Pan,
|
Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer
|
Frontiers in Oncology
|
2021
|
15;11:724655
|
|
Jianwei Lin, Zichao Cao, Dingye Yu,
|
Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
|
Frontiers in Genetics
|
2021
|
17;12:709133
|
|
Zheyu Yang, Yu Heng, Qiwu Zhao, Zichao Cao, Lei Tao, Weihua Qiu,
|
A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer
|
Frontiers in Endocrinology
|
2021
|
30;12:743900
|
|
Juyong Liang, Zhijian Jin, Jie Kuang, Haoran Feng, Qiwu Zhao, Zheyu Yang, Ling Zhan, Baiyong Shen, Jiqi Yan,, Xi Cheng, Weihua Qiu
|
The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis
|
British journal of cancer
|
2021
|
125(3):390-401
|
|
Yu Heng,Zheyu Yang,Liang Zhou,Jianwei Lin,,Lei Tao
|
Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis
|
Endocrine
|
2020
|
10.1007/s12020-020-02194-8.
|
|
Chunting Li, Jiexuan Wang, Xinmiao Lu, Huang Ge, Xin Jin, Qinhua Guan, Yue Su, Ruijun Pan, Peiyong Li,, Xinyuan Zhu
|
Hydrogen peroxide-response nanoprobe for CD44-targeted circulating tumor cell detection and H2O2 analysis
|
Biomaterials
|
2020
|
255:120071
|
|
Chenghao Lu, Zheyu Yang, Dingye Yu, Jianwei Lin,
|
RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer
|
Pathology Research and Practice
|
2020
|
216(11):153142
|
|
Zheyu Yang, Yu Heng, Jianwei Lin, Chenghao Lu, Dingye Yu, Lei Tao,
|
Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers
|
Cancer Research and Treatment
|
2020
|
52(4):1010-1018
|
|
Xiang Z,Huang X,Wang J,Zhang J,Ji J,Yan R,Zhu Z,,Yu Y
|
Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2C+ Gastric Cancer.
|
Frontiers in Pharmacology
|
2018
|
9:861
|
|
Tong Zhou,Maocai Luo,,Siyuan Zhou,Danying Feng,Chundi Xu, HongyanWang
|
Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-β-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110δ
|
EBioMedicine
|
2018
|
31：217–225
|
|
Shi Y,He C,Ma C,Yu T,Cong Y,,Liu Z
|
Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function.
|
Mucosal Immunology
|
2018
|
11(3):835-845
|
|
Hu WG, Pan RJ,, Wang ZT, Zhu ZG.
|
Lack of association between the hOGG1 gene Ser326Cys polymorphism and gastric cancer risk: evidence from a case-control study and a meta-analysis.
|
Genet Mol Res.
|
2015
|
14(4):14670-9.
|
|
, Dong F, Wang Z, Yang X, Zheng M, Che X.
|
Heated and humidified CO? pneumoperitoneum inhibits tumour cell proliferation, migration and invasion in colon cancer.
|
Int J Hyperthermia.
|
2014
|
30(3):201-9.
|
|
, Wang ZT, Zhong J, Zhang Y
|
Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
|
Genet Mol Res
|
2013
|
26;12-14
|
|
, Wang ZT, Li J, Hu JJ, Zhong J
|
Bioequivalence study of two esomeprazole enteric coated formulations in healthy Chinese volunteers.
|
Arzneimittelforschung
|
2011
|
61(9):502-5.
|
|
, Wang ZT, Wu L, Zhong J, Zheng MH.
|
Laparoscopically assisted resections of small bowel stromal tumors are safe and effective.
|
J Dig Dis
|
2011
|
12(6):443-7
|
|